galactose has been researched along with Infections, Pseudomonas in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borbás, A; Csávás, M; Fujdiarová, E; Herczeg, M; Hodek, P; Houser, J; Komárek, J; Malinovská, L; Thai Le, S; Vašková, M; Wimmerová, M | 1 |
| Abbott, J; Bucior, I; Engel, JN; Matthay, MA; Song, Y | 1 |
| Bhaumik, P; Modak, A; Pandey, S; Phale, PS | 1 |
| Hauber, HP; Mack, D; Pforte, A; Schulz, M; Schumacher, U; Zabel, P | 1 |
| Gilboa-Garber, N; Rachmaninov, O; Zinger-Yosovich, KD | 1 |
| Gupta, S; Hazlett, L; Ireland, M; Masinick, S; Rudner, X | 1 |
| Amison, R; Banner, KH; Coulthard, A; Grevot, A; Growcott, EJ; Hardaker, EL; Jones, P; Malt, L; Osborne, C; Poll, C; Saxena, V | 1 |
| Ajiki, Y; Kawada, H; Koga, T; Yasuda, H; Yokota, T | 1 |
| Efimova, TG; Ekzempliarov, ON; Tsyganov, VA | 1 |
1 trial(s) available for galactose and Infections, Pseudomonas
| Article | Year |
|---|---|
Inhalation with fucose and galactose for treatment of Pseudomonas aeruginosa in cystic fibrosis patients.
Topics: Administration, Inhalation; Adult; Aminoglycosides; C-Reactive Protein; Cell Count; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Female; Fucose; Galactose; Gene Expression; Humans; Immunoglobulin Isotypes; Leukocytes, Mononuclear; Liver Function Tests; Male; Neutrophils; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Function Tests; Sputum; Treatment Outcome; Tumor Necrosis Factor-alpha | 2008 |
8 other study(ies) available for galactose and Infections, Pseudomonas
| Article | Year |
|---|---|
Synthesis of β-d-galactopyranoside-Presenting Glycoclusters, Investigation of Their Interactions with
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Bacterial Proteins; Galactose; Humans; Lectins; Pseudomonas aeruginosa; Pseudomonas Infections | 2019 |
Sugar administration is an effective adjunctive therapy in the treatment of Pseudomonas aeruginosa pneumonia.
Topics: Animals; Anti-Bacterial Agents; Bacterial Adhesion; Bronchi; Carbohydrates; Cells, Cultured; Cystic Fibrosis; Fucose; Galactose; Humans; Interleukin-8; Lung Injury; Male; Mannose; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Pneumonia, Bacterial; Polysaccharides; Pseudomonas aeruginosa; Pseudomonas Infections; Trachea | 2013 |
High Resolution Structures of Periplasmic Glucose-binding Protein of Pseudomonas putida CSV86 Reveal Structural Basis of Its Substrate Specificity.
Topics: Amino Acid Sequence; Bacterial Proteins; Binding Sites; Carrier Proteins; Crystallography, X-Ray; Galactose; Glucose; Humans; Models, Molecular; Molecular Sequence Data; Phylogeny; Protein Conformation; Protein Folding; Pseudomonas Infections; Pseudomonas putida; Sequence Alignment; Substrate Specificity | 2016 |
Preventing Pseudomonas aeruginosa and Chromobacterium violaceum infections by anti-adhesion-active components of edible seeds.
Topics: Adhesins, Bacterial; Anacardium; Animals; Bacterial Adhesion; Blotting, Western; Cacao; Chromobacterium; Coffee; Egg White; Fatty Acids; Galactose; Glycoproteins; Hemagglutination Inhibition Tests; Lectins; Milk; Plant Extracts; Protein Binding; Pseudomonas aeruginosa; Pseudomonas Infections; Seeds; Solanum lycopersicum | 2012 |
In the immature mouse, Pseudomonas aeruginosa pili bind a 57-kd (alpha 2-6) sialylated corneal epithelial cell surface protein: a first step in infection.
Topics: Animals; Animals, Newborn; Bacterial Adhesion; Binding, Competitive; Cornea; Electrophoresis, Polyacrylamide Gel; Epithelium; Eye Proteins; Female; Fimbriae, Bacterial; Galactose; Membrane Glycoproteins; Mice; Molecular Weight; Pregnancy; Pseudomonas aeruginosa; Pseudomonas Infections; Sialic Acids | 1995 |
Characterisation of a refined rat model of respiratory infection with Pseudomonas aeruginosa and the effect of ciprofloxacin.
Topics: Acute Disease; Agar; Animals; Anti-Infective Agents; Bacterial Load; Bronchoalveolar Lavage Fluid; Ciprofloxacin; Disease Models, Animal; Hexoses; Leukocyte Count; Male; Microspheres; Neutrophils; Particle Size; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections; Time Factors; Treatment Outcome | 2011 |
Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin.
Topics: Alginates; Animals; Bacterial Proteins; Clarithromycin; Filtration; Hexoses; Male; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Skin | 1993 |
[Physico-chemical properties and biological activity of lipopolysaccharides from Streptoverticillium sp. No 0223].
Topics: Actinomycetales; Animals; Candidiasis; Escherichia coli Infections; Fatty Acids; Fatty Acids, Essential; Glucosamine; Hexoses; Lipopolysaccharides; Mice; Pseudomonas Infections; Staphylococcal Infections | 1969 |